Cover Page

About apc

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Case Report 
Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma—two case reports
Lawrence W. Wu, Syed M. Qasim Hussaini, Jae W. Lee, Daniel H. Shu, Ralph H. Hruban, Daniel A. Laheru
Annals of Pancreatic Cancer  
2022;
5:
6  
Case Report 
Pancreatic neuroendocrine tumor in a 27-year-old patient with Cornelia de Lange syndrome: a case report
Michael J. Wright, Antonie D. Kline, Christopher L. Wolfgang, Ammar A. Javed
Annals of Pancreatic Cancer  
2022;
5:
5  
Original Article 
EBF2 contributes to pancreatic cancer progenitor cell differentiation and tumor suppression
Hannah Mathew, Jennifer J. Barb, Soren Bentzen, Sheelu Varghese
Annals of Pancreatic Cancer  
2022;
5:
4  
Review Article
 
Drain and nasogastric tube use following pancreatoduodenectomy: a narrative review
Thomas B. Russell, Peter L. Labib, Somaiah Aroori
Annals of Pancreatic Cancer  
2022;
5:
3  
Review Article
 
Selected intra-operative factors which affect pancreaticoduodenectomy outcomes: a narrative review
Thomas B. Russell, Peter L. Labib, Somaiah Aroori
Annals of Pancreatic Cancer  
2022;
5:
2  
Original Article 
Blood transfusion is associated with worse outcomes following pancreatic resection for pancreatic adenocarcinoma
Ammar A. Javed, Sean M. Ronnekleiv-Kelly, Alina Hasanain, Michael J. Pflüger, Joseph R. Habib, Michael J. Wright, Jin He, John L. Cameron, Christopher L. Wolfgang, Steven M. Frank, Matthew J. Weiss, Richard A. Burkhart
Annals of Pancreatic Cancer  
2022;
5:
1  
Review Article
 
Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review
Thomas B. Russell, Peter L. Labib, Somaiah Aroori
Annals of Pancreatic Cancer  
2021;
4:
10  
Case Report 
Case series: FDG-avid lymphadenopathy during oncologic staging of pancreatic adenocarcinoma after COVID-19 vaccination
John M. Nathan, Patrick J. Navin, Mark J. Truty, Benzon M. Dy
Annals of Pancreatic Cancer  
2021;
4:
9  
Review Article
 
The robotic central pancreatectomy: surgical technique, and literature review
Krishna Kotecha, Advait Pandya, Ramesh Damodaran Prabha, Rudra Maitra, Anubhav Mittal, Jaswinder S. Samra
Annals of Pancreatic Cancer  
2021;
4:
8  
Original Article 
Pancreatic adenocarcinoma in liver transplant recipients: a case series
Muhammad A. Rauf, Ioannis A. Ziogas, Julia M. Sealock, Lea K. Davis, Manhal Izzy, Sophoclis P. Alexopoulos, Lea K. Matsuoka
Annals of Pancreatic Cancer  
2021;
4:
6  
Review Article
 
Solid pseudopapillary neoplasm of the pancreas: cytomorphology, pitfalls, and literature review
Payam S. Pahlavan, Amer Khiyami, Santhi Ganesan
Annals of Pancreatic Cancer  
2021;
4:
5  
Review Article
 
Volatile organic compound analysis for the diagnosis of pancreatic cancer
Benjamin T. Crosby, Adam Ridzuan-Allen, John P. O’Neill
Annals of Pancreatic Cancer  
2021;
4:
4  
Original Article 
A national database analysis of acinar cell carcinoma of the pancreas, a histologically, epidemiologically, and biologically distinct entity increasing in incidence
Jennifer A. Yonkus, John R. Bergquist, Roberto Alva-Ruiz, Tommy Ivanics, Elizabeth B. Habermann, Amro M. Abdelrahman, Travis E. Grotz, Sean P. Cleary, Rory L. Smoot, David M. Nagorney, Michael L. Kendrick, Thorvardur R. Halfdanarson, Mark J. Truty
Annals of Pancreatic Cancer  
2021;
4:
3  
Original Article 
A Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma
Jeffrey W. Clark, Nora Horick, Jill N. Allen, Lawrence S. Blaszkowsky, Janet E. Murphy, Charles S. Fuchs, Brian M. Wolpin, Robert J. Mayer, Jason E. Farris, Jennifer A. Chan, Kimmie Ng, Nadine J. McCleary, Thomas A. Abrams, David P. Ryan, Eunice L. Kwak, Theodore S. Hong
Annals of Pancreatic Cancer  
2021;
4:
2  
Original Article 
Association of germline ATM mutations and survival in pancreatic cancer
Arjan Gower, Gillian Gresham, Kellie Spector, Nanor Haladjian, John Lee, Sejal Mehta, Arsen Osipov, Andrew Hendifar
Annals of Pancreatic Cancer  
2021;
4:
1  
Review Article
 
Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions
Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart
Annals of Pancreatic Cancer  
2020;
3:
17  
Original Article 
MRI screening in hereditary pancreatic cancer: value of various sequences in the detection of early pancreatic cancer
Bas Boekestijn, Shirin Feshtali, Arnoud C. Meijer, Isaura S. Ibrahim, Arantza Farina-Sarasqueta, Akin Inderson, Bert A. Bonsing, Andrew G. Webb, Hans F. Vasen, Martin N. Wasser
Annals of Pancreatic Cancer  
2020;
3:
16  
Original Article 
Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging
Joy Liau, Srinivasan Vedantham, Hani M. Babiker, Travis McGlothin, Diego R. Martin
Annals of Pancreatic Cancer  
2020;
3:
15  
Case Report 
Primary squamous cell carcinoma of the pancreas: case report and literature review
Arig Abas Mussa, Ciaran F. Healy, Julie McCarthy
Annals of Pancreatic Cancer  
2020;
3:
14  
Currently no content available!

Original Article

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging
Joy Liau, Srinivasan Vedantham, Hani M. Babiker, Travis McGlothin, Diego R. Martin
Nonselective β-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival
Alex B. Blair, Noelle R. Jurcak, Ammar Javed, Jonathan Teinor, Vincent P. Groot, Noah Rozich, John L. Cameron, Matthew J. Weiss, Jin He, Christopher L. Wolfgang, Lei Zheng, Richard A. Burkhart
Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution
Alejandro Recio-Boiles, Jessica Vondrak, Summana Veeravelli, James J. Mancuso, Kathylynn Saboda, Denise J. Roe, Irbaz Bin Riaz, Aaron J. Scott, Emad Elquza, Ali McBride, Hani M. Babiker
Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma
May Tun Saung, Lei Zheng
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma
Alejandro Recio-Boiles, Aparna Nallagangula, Summana Veeravelli, Jessica Vondrak, Kathylynn Saboda, Denise Roe, Emad Elquza, Ali McBride, Hani M. Babiker

Review Article


Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions
Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart
Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
Mengni He, MacKenzie Henderson, Stephen Muth, Adrian Murphy, Lei Zheng
Targeting homologous recombination addicted tumors: challenges and opportunities
Talia Golan, Jonathan R. Brody
Evolving trends in pancreatic cancer therapeutic development
Imani Bijou, Jin Wang
Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors
Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang, Bu Jung Kim, Thomas J. Fahey III, Yi-Chieh Nancy Du
Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma
Yi Xu, Jun Liu, Michael Nipper, Pei Wang
Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon
Noah S. Rozich, Caitlin E. Jones, Katherine T. Morris
Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence
Adam R. Wolfe, Terence M. Williams
Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy
Sweet Ping Ng, Eugene J. Koay
Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma
Nikhil Yegya-Raman, Mihir M. Shah, Miral S. Grandhi, Elizabeth Poplin, David A. August, Timothy J. Kennedy, Usha Malhotra, Kristen R. Spencer, Darren R. Carpizo, Salma K. Jabbour
Robotic distal pancreatectomy: greatest benefit for the frail?
Ioannis T. Konstantinidis, Laleh G. Melstrom

Perspective


Immune defects in pancreatic cancer
Lei Zheng